Tuesday, January 31, 2023

Govt admits multiple side-effects of Covid-19 vaccines in RTI reply

In a shocking revelation about the Government’s two top watchdogs have admitted to ‘multiple side-effects’ of Covid-19 vaccines that were administered to over a billion Indians in the past more than two years. The shocking revelations of ‘multiple side-effects’ of the coronavirus vaccine were made by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) when they replied to an RTI filed by Pune businessman Prafful Sarda.
India has permitted AstraZenaca and Serum Institute of India, Pune’s ‘Covishield’ and SII’s own ‘Covovax’; vaccines of three Hyderabad-based companies — the government-run Bharat Biotech Ltd.’s ‘Covaxin’, Dr. Reddy’s Lab imported ‘Sputnik V’, Biological E. Ltd.’s ‘CorBEvax’, and later, Cadila Healthcare Ltd., Ahmedabad’s ‘ZyCov-D’ only for teenagers (12-17 age), reported IANS.
In a specific query by Sarda on the side-effects of all these jabs, the ICMR’s PIO Dr. Leyanna Susan George and CDSCO’s PIO Sushanta Sarkar, have cited a plethora of ramifications arising out of all these vaccines comprising their FAQs.
Covishield side-effects: According to a report by IANS, Covishield takes the lion’s share of its after-effects on the jabbed masses — injection site tenderness or pain, multiple red spots or bruises beyond the injected site, persistent vomiting without reasons, severe or persistent abdominal pains or headaches with or without vomiting, shortness of breath, chest pains, pain in limbs or swelling on pressing of calf/arms, weakness/paralysis of limbs of any particular side or parts of the body, including cranial nerves, unprecedented seizures, pain in eyes, blurred vision or diplopia, change in mental status, encephalopathy or depressed level of consciousness.
Side-effects of Covovax: Covovax side-effects are injection site pain/tenderness/induration, fatigue, malaise, headaches, fever, soreness of muscles, joint pains, nausea or vomiting, chills, body-ache or extreme pain in limbs, Asthenia (weakness or lack of energy), Injection site pruritus (itching, rash, red skin, hives), enlarged lymph nodes, back pains, and rarely dizziness or drowsiness, reported IANS
Side effects of Covaxin, Sputnik V, CorBEvax: Covaxin displays mild symptoms AEFIs like injection site pain/swelling, headaches, fatigue, fever, bodyache, abdominal pain, nausea, vomiting, dizziness, giddiness, tremors, sweating, cold and cough.
Sputnik V manifests with chills, fever, arthralgia, myalgia, asthenia, headaches, general discomfort, injection site pain/swelling/hyperaemia, or nausea, dyspepsia, loss of appetite, or occasional enlarged regional lymph nodes.
CorBEvax shows effects like fever/pyrexia, headaches, fatigue, body pains, myalgia, nausea, or arthralgia, urticaria, chills, lethargy, besides injection site pain/erythema, swelling, rash, pruritis or irritation.
“The replies by ICMR-CDSCO are blatantly shocking. Though the government has declared that “vaccination is totally voluntary”, why was the compulsion created indirectly by barring people from travelling in buses, trains, flights, inter-state movements, going out to hotels, restaurants, multiplexes, malls, etc. This trapped more and more panicked people into getting themselves jabbed without knowing the after-effects,” Sarda told IANS.
Sarda also asked the government to release the data on whether the media, hospitals, and vaccination centres did adequate publicity on all these possible side-effects and if the health ministry initiated any public safety campaigns for the gullible masses, now that vaccine-related deaths are being reported in India and worldwide.
Sarda cited how India had donated crores of free vaccines — leading to an uproar in 2021 — to many poor countries worldwide and questioned whether all the potential complications of the jabs were brought to the notice of the people in those nations.
“All the global agencies have set the benchmark that only those vaccine candidates that show an efficacy of at least 50-60 per cent will be considered. Most of the vaccines have shown the efficacy of 70-90 per cent within the short period of two or three months of observation. More than 100 crore people have received at least a single dose of Covid-19 vaccine and the proportion of side effects is very low,” the government has assured, reported IANS.
After the initial mass-vaccinations, mostly free was completed, from August 2022, the government has permitted conditional market sales of Covishield and Covaxin but the others — Sputnik V and CorBEvax — remain specifically for “restricted emergency use”, as per the RTI.
Meanwhile, the number of cases of COVID-19’s XBB.1.5 variant, responsible for the rise in cases in the US, has gone up to 26 in India, according to INSACOG data on Monday..The cases of XBB.1.5 variant have been found across 11 states and Union territories till now, including Delhi, Maharashtra and West Bengal, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said.
The XBB.1.5 strain is a relative of the Omicron XBB variant, which is a recombinant of the Omicron BA.2.10.1 and BA.2.75 subvariants. Combined, XBB and XBB.1.5 make up 44 per cent of cases in the US.
The INSACOG data also showed that 14 cases of BF.7 strain which is apparently driving China’s COVID-19 wave have been found in India.
There are four cases of Omicron sub-variant BF.7 reported in West Bengal, three in Maharashtra, two each in Haryana and Gujarat and one each in Odisha, Delhi and Karnataka.
INSACOG reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India.

Must Read